The influence of administration of epoetin beta pegol (CERA) and saccharated ferric oxide on erythroferron and hepcidin of hemodialyzed patients
Not Applicable
- Conditions
- Hemodialyzed patients with renal anemia
- Registration Number
- JPRN-UMIN000016552
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Inflammation, iron excess, malignancy and gastro-intestinal, hepatic, and bone marrow diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Erythropoiesis: Hb, reticulocytes, CHr Iron metabolism: serum iron, UIBC, ferritin, erythroferron et al.
- Secondary Outcome Measures
Name Time Method